General MedicationsORALGeneric
THEOPHYLLINE
THEOPHYLLINE
Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview THEOPHYLLINE is listed in Drugs@FDA under application 218401 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2025-03-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview THEOPHYLLINE is listed in Drugs@FDA under application 218401 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2025-03-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.